Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats

MLA

Šárka Vacková, et al. “Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats.” Frontiers in Pharmacology, vol. 10, Jan. 2019. EBSCOhost, https://doi.org/10.3389/fphar.2019.00018.

APA

Šárka Vacková, Libor Kopkan, Soňa Kikerlová, Zuzana Husková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Bruce D. Hammock, John D. Imig, Miloš Táborský, Vojtěch Melenovský, & Luděk Červenka. (2019). Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.00018

Chicago

Šárka Vacková, Libor Kopkan, Soňa Kikerlová, Zuzana Husková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Bruce D. Hammock, et al. 2019. “Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats.” Frontiers in Pharmacology 10 (January). doi:10.3389/fphar.2019.00018.